摘要
目的：探讨硝苯吡啶治疗急性心梗塞的疗效。方法：随机将２２８例ＡＭＩ分为三组，硝苯吡啶组和硝苯吡啶加β受体阻滞剂组及对照组。结果：硝苯吡啶组１０２例，死亡１１例，死亡率１０．７２％；硝苯吡啶加β受体阻滞剂组３９例，死亡５例，死亡率为１２．８２％；对照组８７例，死亡１２例，死亡率为１３．７９％。结论：三组相比硝苯吡啶组死亡率最低，但无统计学意义，Ｐ〉０．０５，故我们认为硝苯吡啶１０ｍｇ。
To study the effelct and aafety of nefedipine on acute myocardial infarction,228 patients were randomly divided into 3 groups, ie nefedipine group,nefedipin and β-aaeptor blocker group,control group,Results:The mortality was 10.70%(11 of 102 patients) in mefedipine group,12.82%(5 39 patients)in nefedipine and β-accaptor blocker group,and 13.79%(12 of 87 ptients) in control group.The mortality in nefedipin group was the lowest,but there was nostatistical significance amony 3 group P>0.05.The results showe that in chinese patients with acute myocardial infarction,nefedipine 30mg/douy was relativelyeffeetive and safe.
